Company · CIK 0001861560 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Nuvalent, Inc. · NUVL
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 DUForm 4 → | Jul 17, 3:27 pm EDT | James E Flynn +7Director, 10% Owner | 17,262,186 | $124.00 | $2,140,511,064 | 0 | — | |
| Jul 15, 2026 DUForm 4 → | Jul 15, 7:11 pm EDT | Michael L. MeyersDirector | 8,590 | $124.00 | $638,104 | 0 | — | |
| Jul 15, 2026 ADUForm 4 → | Jul 15, 7:11 pm EDT | Alexandra BalcomChief Financial Officer | 114,233 | $124.00 | $5,509,692 | 0 | — | |
| Jul 15, 2026 DUForm 4 → | Jul 15, 7:07 pm EDT | Sapna SrivastavaDirector | 8,590 | $124.00 | $638,104 | 0 | — | |
| Jul 15, 2026 DUForm 4 → | Jul 15, 7:04 pm EDT | Christy J. OligerDirector | 7,415 | $124.00 | $164,176 | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 15, 7:03 pm EDT | Ron SquarerDirector | 6,281 | — | — | 0 | — | |
| Jul 15, 2026 ADUForm 4 → | Jul 15, 6:57 pm EDT | Christopher Durant TurnerChief Medical Officer | 101,330 | $124.00 | $3,909,720 | 0 | — | |
| Jul 15, 2026 ADUForm 4 → | Jul 15, 6:57 pm EDT | Darlene NociChief Development Officer | 86,817 | $124.00 | $2,110,108 | 0 | — | |
| Jul 15, 2026 ADUForm 4 → | Jul 15, 6:50 pm EDT | Benjamin LaneSee Remarks | 64,765 | $124.00 | $2,615,408 | 0 | — | |
| Jul 15, 2026 ADUForm 4 → | Jul 15, 6:47 pm EDT | Henry E. PelishChief Scientific Officer | 92,193 | $124.00 | $2,776,732 | 0 | — | |
| Jul 15, 2026 ADUForm 4 → | Jul 15, 6:43 pm EDT | James Richard PorterPresident and CEO, Director | 404,929 | $124.00 | $25,237,596 | 0 | — | |
| Jul 15, 2026 ADUForm 4 → | Jul 15, 6:42 pm EDT | Deborah Ann MillerChief Legal Officer | 88,334 | $124.00 | $2,298,216 | 0 | — | |
| Jul 15, 2026 DUForm 4 → | Jul 15, 6:36 pm EDT | Anna ProtopapasDirector | 8,590 | $124.00 | $638,104 | 0 | — | |
| Jul 15, 2026 DUForm 4 → | Jul 15, 6:35 pm EDT | Grant C. BogleDirector | 9,291 | $124.00 | $460,536 | 0 | — | |
| Jul 15, 2026 DUForm 4 → | Jul 15, 6:35 pm EDT | Cameron WheelerDirector | 8,590 | $124.00 | $638,104 | 0 | — | |
| Jul 9, 2026 SForm 4 → | Jul 10, 4:30 pm EDT | Henry E. PelishChief Scientific Officer | 2,111 | $123.81 | $261,363 | 63,493 | −3.22% | 10b5-1 |
| Jul 6, 2026 SForm 4 → | Jul 8, 4:30 pm EDT | James Richard PorterPresident and CEO, Director | 30,000 | $123.72 | $3,711,600 | 324,879 | −8.45% | 10b5-1 |
| Jul 6, 2026 MForm 4 → | Jul 8, 4:30 pm EDT | James Richard PorterPresident and CEO, Director | 30,000 | $18.93 | $567,900 | 354,879 | — | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 6, 4:31 pm EDT | Darlene NociChief Development Officer | 23,000 | $123.59 | $2,842,570 | 58,117 | −28.4% | 10b5-1 |
| Jul 1, 2026 MForm 4 → | Jul 6, 4:31 pm EDT | Darlene NociChief Development Officer | 23,000 | $51.11 | $1,175,471 | 81,117 | — | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 6, 4:30 pm EDT | Alexandra BalcomChief Financial Officer | 11,430 | $123.58 | $1,412,519 | 85,533 | −11.8% | 10b5-1 |
| Jul 1, 2026 MForm 4 → | Jul 6, 4:30 pm EDT | Alexandra BalcomChief Financial Officer | 11,430 | $13.26 | $151,547 | 96,963 | — | 10b5-1 |
| Jun 29, 2026 SForm 4 → | Jul 1, 4:30 pm EDT | Darlene NociChief Development Officer | 5,500 | $123.51 | $679,305 | 58,117 | −8.65% | 10b5-1 |
| Jun 29, 2026 MForm 4 → | Jul 1, 4:30 pm EDT | Darlene NociChief Development Officer | 5,500 | $27.85 | $153,175 | 63,617 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 DForm 4 → | Jul 17, 3:27 pm EDT | James E Flynn +7Director, 10% Owner | 5,607,126 | $124.00 | $673,971,496 | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 15, 7:11 pm EDT | Michael L. MeyersDirector | 71,297 | — | — | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 15, 7:11 pm EDT | Alexandra BalcomChief Financial Officer | 335,432 | — | — | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 15, 7:07 pm EDT | Sapna SrivastavaDirector | 111,436 | — | — | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 15, 7:04 pm EDT | Christy J. OligerDirector | 6,119 | — | — | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 15, 7:03 pm EDT | Ron SquarerDirector | 4,418 | — | — | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 15, 6:57 pm EDT | Christopher Durant TurnerChief Medical Officer | 659,640 | — | — | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 15, 6:57 pm EDT | Darlene NociChief Development Officer | 212,653 | — | — | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 15, 6:50 pm EDT | Benjamin LaneSee Remarks | 80,989 | — | — | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 15, 6:47 pm EDT | Henry E. PelishChief Scientific Officer | 118,253 | — | — | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 15, 6:43 pm EDT | James Richard PorterPresident and CEO, Director | 2,028,968 | — | — | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 15, 6:42 pm EDT | Deborah Ann MillerChief Legal Officer | 311,262 | — | — | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 15, 6:36 pm EDT | Anna ProtopapasDirector | 77,936 | — | — | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 15, 6:35 pm EDT | Grant C. BogleDirector | 8,998 | — | — | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 15, 6:35 pm EDT | Cameron WheelerDirector | 85,936 | — | — | 0 | — | |
| Jul 6, 2026 MForm 4 → | Jul 8, 4:30 pm EDT | James Richard PorterPresident and CEO, Director | 30,000 | — | — | 118,686 | — | 10b5-1 |
| Jul 1, 2026 MForm 4 → | Jul 6, 4:31 pm EDT | Darlene NociChief Development Officer | 23,000 | — | — | 33,646 | — | 10b5-1 |
| Jul 1, 2026 MForm 4 → | Jul 6, 4:30 pm EDT | Alexandra BalcomChief Financial Officer | 11,430 | — | — | 22,933 | — | 10b5-1 |
| Jun 29, 2026 MForm 4 → | Jul 1, 4:30 pm EDT | Darlene NociChief Development Officer | 5,500 | — | — | 81,329 | — | 10b5-1 |